08048035968
Cancer TEMOTERO 250mg Capsules trusted to Canada - Toronto | Phoenix Exim | Global Exporter

. General Information

Temotero 250 mg Capsule is an anti-neoplastic/chemotherapy medicine containing temozolomide. It is prescribed by specialist doctors for specific brain tumors and may be used with radiotherapy or as subsequent maintenance treatment, depending on the patient's diagnosis and treatment plan.

Product: Temotero 250 mg Capsules
Active ingredient: Temozolomide 250 mg
Dosage form: Oral capsule
Therapeutic class: Antineoplastic / alkylating agent
Manufacturer/marketer: Hetero Healthcare / Hetero Drugs
Pack: Commonly 5 capsules per pack
Prescription: Prescription-only medicine

2. Product Information

Temotero 250 mg is an oral formulation of temozolomide. The medicine is designed to interfere with the DNA of cancer cells, reducing their ability to grow and divide. Temotero 250 mg is available in a 250 mg strength and should be used strictly according to an oncologist's prescription.

For international supply, Phoenix Exim, Nagpur, India, can present Temotero 250 mg Capsules for pharmaceutical sourcing and export enquiries, subject to applicable prescription, import, and regulatory requirements in the destination country.

3. Uses of Temotero 250 mg

Temotero is primarily used for certain forms of malignant brain tumors, including:

  • Newly diagnosed glioblastoma multiforme, generally as part of a treatment regimen involving radiotherapy.
  • Malignant gliomas that have returned or progressed following standard treatment.
  • Anaplastic astrocytoma in appropriate patients.
  • Other uses only when specifically determined appropriate by a qualified specialist.

4. Benefits of This Medicine

When appropriately prescribed, Temotero may:

  • Help slow or control the growth of certain malignant brain tumors.
  • Damage cancer-cell DNA and interfere with cancer-cell multiplication.
  • Be incorporated into treatment protocols alongside radiotherapy.
  • Be used as maintenance therapy in selected patients.
  • Provide an oral chemotherapy option for appropriate patients.

Important: These are therapeutic purposes, not a guarantee of treatment success. Response varies according to tumor type, stage, molecular characteristics, previous treatment and individual patient factors.

5. Side Effects

Temozolomide can cause side effects because it affects rapidly dividing cells and can also suppress bone marrow function. Reported adverse effects include:

  • Nausea
  • Vomiting
  • Headache
  • Fatigue
  • Constipation
  • Loss of appetite
  • Hair loss
  • Increased susceptibility to infections
  • Reduced blood-cell counts
  • Fever or other signs of infection

Some adverse reactions can be serious. Patients should contact their treating healthcare professional promptly if they develop fever, unusual bleeding/bruising, severe weakness, breathing difficulties, or other concerning symptoms.

6. Common Side Effects

Commonly reported effects include:

  1. Nausea and vomiting
  2. Fatigue or weakness
  3. Headache
  4. Constipation
  5. Loss of appetite
  6. Hair loss
  7. Reduced blood-cell counts

Regular monitoring is important because temozolomide can cause myelosuppression, which may increase the risk of infection or bleeding.

7. How to Use Temotero 250 mg

  • Take Temotero exactly as prescribed by your oncologist.
  • The capsule should generally be swallowed whole with water.
  • Do not crush, chew, open or alter the capsule unless specifically instructed by a healthcare professional.
  • Follow the prescribed treatment cycle and dosing schedule carefully.
  • It may be prescribed with or without food; if your doctor gives a specific instruction regarding food, follow that instruction consistently.
  • Do not take an extra dose if you miss a dose unless your healthcare professional instructs you to do so.
  • Never change the dose or discontinue treatment without consulting your oncologist.

8. How This Medicine Works

Temozolomide is an alkylating agent. After administration, it forms active compounds that can modify DNA within cancer cells. This DNA damage interferes with the cancer cell's ability to replicate and divide, eventually contributing to cancer-cell death.

This mechanism is particularly useful in the treatment of certain malignant brain tumors.

9. Safety Advice

Prescription use: Temotero 250 mg should only be used under specialist medical supervision.

Blood tests: Regular blood counts are important because treatment can reduce white blood cells, platelets and other blood-cell levels.

Liver and kidney conditions: Inform your doctor if you have liver or kidney problems before starting treatment.

Pregnancy: Temozolomide may cause fetal harm. Patients who could become pregnant should discuss effective contraception with their doctor.

Breastfeeding: Breastfeeding is generally not recommended during treatment because of the potential risk to the infant.

Infections: Seek medical advice promptly for fever or other signs of infection.

Other medicines: Tell your doctor about all prescription medicines, non-prescription medicines and supplements you take because interactions may occur.

Storage: Store according to the product label, away from excessive heat and moisture and out of children's reach. Some product information specifies storage below 30°C.

10. FAQs

Q1. What is Temotero 250 mg used for?
Temotero 250 mg is primarily used for certain malignant brain tumors, including glioblastoma and anaplastic astrocytoma, under specialist supervision.

Q2. What is the active ingredient in Temotero 250 mg?
It contains Temozolomide 250 mg.

Q3. Is Temotero 250 mg a prescription medicine?
Yes. It is a prescription anticancer medicine and should be used only under medical supervision.

Q4. Can Temotero be taken without a doctor's prescription?
No. The dose and treatment cycle depend on the cancer type, treatment protocol and patient-specific factors.

Q5. Can Temotero be used with radiotherapy?
Yes. In newly diagnosed glioblastoma, temozolomide may be incorporated into a treatment regimen with radiotherapy, followed by maintenance treatment in appropriate patients.

Q6. What are the common side effects?
Nausea, vomiting, fatigue, headache, constipation, appetite loss, hair loss and changes in blood-cell counts are among the reported effects.

Q7. Does Temotero require regular blood tests?
Yes. Blood-count monitoring is important during treatment because temozolomide can suppress bone marrow function.

Q8. Can the capsule be opened or chewed?
It should generally be swallowed whole. Follow your oncologist's instructions for administration.

Q9. Can Temotero be used during pregnancy?
Temozolomide can harm an unborn baby. Pregnancy should be avoided during treatment, and appropriate contraception should be discussed with the treating doctor.

Q10. Who should determine the dose?
The treating oncologist should determine the dose and treatment schedule based on the patient's condition and treatment protocol.

11. Substitutes for Temotero 250 mg

A substitute should contain the same active ingredient, strength and dosage form and should only be selected after consultation with the prescribing doctor or pharmacist.

One listed same-composition alternative is Glioz 250 mg Capsule, which contains temozolomide 250 mg and is manufactured by Dr. Reddy's Laboratories. Availability can vary by country and pharmacy.

Other temozolomide brands may also be available in different markets, but the treating physician should confirm that the alternative is appropriate before substitution.

12. SEO Keywords

  • Temotero 250 mg Capsules exporter from India
  • Temotero 250 mg Capsules supplier in India
  • Temotero 250 mg Temozolomide Capsules exporter
  • Temotero 250 mg medicine exporter from Nagpur
  • Temotero 250 mg Capsules pharmaceutical exporter
  • Temotero 250 mg Capsules supplier from Nagpur India
  • Temozolomide 250 mg Capsules exporter India
  • Temozolomide 250 mg oncology medicine supplier
  • Temotero 250 mg brain cancer medicine supplier
  • Temotero 250 mg glioblastoma medicine exporter
  • Buy Temotero 250 mg Capsules from India
  • Temotero 250 mg Capsules international supplier
  • Temotero 250 mg Capsules export supplier
  • Temotero 250 mg oncology medicine exporter
  • Temotero 250 mg anti cancer medicine supplier
  • Temotero 250 mg Capsules to USA
  • Temotero 250 mg Capsules to UK
  • Temotero 250 mg Capsules to Australia
  • Temotero 250 mg Capsules to Singapore
  • Temotero 250 mg Capsules to Canada
  • Temotero 250 mg Capsules to South Korea
  • Temotero 250 mg Capsules to UAE
  • Temozolomide 250 mg supplier India to USA
  • Temozolomide 250 mg exporter India to UK
  • Temotero 250 mg pharmaceutical supplier Nagpur India
  • Genuine Temotero 250 mg Capsules supplier
  • Temotero 250 mg prescription oncology medicine exporter
  • Temotero 250 mg brain tumor medicine supplier
  • Temotero 250 mg chemotherapy medicine exporter
  • Temotero 250 mg Capsules wholesale pharmaceutical supplier
Aug 21st, 2026 3:31 PM

Keywords